Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised clinical trial of ivermectin for treatment and prophylaxis of COVID-19
2020-001994-66Phase 3Terminated
- Sponsor
- Fundació Assistencial de Mútua de Terrassa
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Fundació Assistencial de Mútua de Terrassa. Primary endpoint: Primary endpoints (Sub-study 1). Started May 2020; status: terminated.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001994-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001994-66.